dr. andrew zelenetz on targeted therapies for diffuse large b-cell lymphoma
Published 12 years ago • 1.6K plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
9:05
understanding car t-cell therapy for lymphoma with andrew zelenetz, md, phd
-
1:24
dr. andrew zelenetz discusses treatment options for dlbcl
-
1:58
dr. zelenetz on current treatment options for mcl
-
2:11
dr. zelenetz discusses cd30 as a target in lymphoma
-
7:23
diffuse large b-cell lymphoma (dlbcl) regimens
-
5:17
selecting between targeted therapies in b-cell lymphomas
-
1:26:39
novel treatments for lymphoma: focus on targeted therapies
-
0:39
what is targeted therapy for treating non-hodgkin lymphomas? (from chapter 3)
-
1:37:39
an update on t-cell lymphoma
-
7:11
lymphoma dlbcl coping with chemo
-
10:09
understanding diffuse large b-cell lymphoma with jennifer amengual, md
-
2:30
dr. andrew zelenetz on the treatment of hematologic malignancies
-
1:13
dr. andrew zelenetz on the impact of rituximab in lymphoma
-
39:36
17. targeted therapy for non-hodgkin lymphoma – dr cathy burton
-
1:04
the potential of targeted therapy in dlbcl: open questions
-
1:31
dr. zelenetz on progress made in mcl treatment
-
39:46
immunotherapy chat w/ drs. andrew zelenetz and lia palomba at memorial sloan kettering cancer center
-
1:48
dr. zelenetz highlights studies from the 2012 ash meeting
-
1:38
dr. zelenetz on anticipated research in mcl
-
3:01
candidates for car t-cell therapy in dlbcl
-
5:03
selecting from car t-cell therapies in dlbcl
-
3:46
the future of treatment of b-cell lymphoma